- Home
- OCS vs TRIN Comparison
OCS vs TRIN Comparison
Compare OCS & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- TRIN
- Stock Information
- Founded
- OCS 2003
- TRIN 2007
- Country
- OCS Switzerland
- TRIN United States
- Employees
- OCS N/A
- TRIN N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- TRIN Finance/Investors Services
- Sector
- OCS Health Care
- TRIN Finance
- Exchange
- OCS Nasdaq
- TRIN Nasdaq
- Market Cap
- OCS 904.3M
- TRIN 1.0B
- IPO Year
- OCS N/A
- TRIN 2021
- Fundamental
- Price
- OCS $19.03
- TRIN $15.16
- Analyst Decision
- OCS Strong Buy
- TRIN Hold
- Analyst Count
- OCS 4
- TRIN 3
- Target Price
- OCS $29.50
- TRIN $15.33
- AVG Volume (30 Days)
- OCS 42.6K
- TRIN 553.4K
- Earning Date
- OCS 03-11-2025
- TRIN 04-30-2025
- Dividend Yield
- OCS N/A
- TRIN 13.46%
- EPS Growth
- OCS N/A
- TRIN 11.47
- EPS
- OCS N/A
- TRIN 2.10
- Revenue
- OCS $757,024.00
- TRIN $226,729,000.00
- Revenue This Year
- OCS $927.26
- TRIN $22.86
- Revenue Next Year
- OCS $292.79
- TRIN $9.30
- P/E Ratio
- OCS N/A
- TRIN $7.21
- Revenue Growth
- OCS N/A
- TRIN 29.68
- 52 Week Low
- OCS $10.55
- TRIN $13.05
- 52 Week High
- OCS $23.08
- TRIN $16.82
- Technical
- Relative Strength Index (RSI)
- OCS 42.80
- TRIN 35.46
- Support Level
- OCS $18.30
- TRIN $16.02
- Resistance Level
- OCS $20.00
- TRIN $16.18
- Average True Range (ATR)
- OCS 0.71
- TRIN 0.24
- MACD
- OCS 0.09
- TRIN -0.08
- Stochastic Oscillator
- OCS 61.35
- TRIN 26.20
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About TRIN Trinity Capital Inc.
Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.